Related Experiment Video
Updated: Feb 12, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study
Gary M Woods1, Ruchika Sharma2, Susan Creary3
1Division of Pediatric Hematology/Oncology, Children's Hospital of the King's Daughters, Norfolk, VA.
Insights
Nearly 3% of children with sickle cell disease (SCD) experienced venous thromboembolism (VTE). Central venous catheter (CVC) use was identified as an independent risk factor for VTE in this pediatric population.
Area of Science:
- Hematology
- Pediatric Thrombosis
- Sickle Cell Disease Research
Background:
- Sickle cell disease (SCD) is a genetic blood disorder associated with an increased risk of venous thromboembolism (VTE).
- Understanding VTE incidence and risk factors in pediatric SCD patients is crucial for effective prevention and management strategies.
Purpose of the Study:
- To determine the cumulative incidence of VTE in children with SCD.
- To identify clinical risk factors associated with VTE development in this patient group.
Main Methods:
- Retrospective chart review of pediatric patients (0-21 years) with SCD at a single institution over a 6-year period.
- Data collected included VTE diagnosis, demographics, SCD genotype, clinical complications, central venous catheter (CVC) placement, and thrombophilia testing.
Main Results:
- The cumulative incidence of VTE was 2.9% (12/414) among children with SCD.
- Central venous catheter (CVC) presence was the only independent risk factor for VTE on multivariable analysis (OR 33.8).
- Other univariate risk factors included hemoglobin SS genotype, central nervous system vasculopathy, chronic transfusion therapy, and older age.
Conclusions:
- Approximately 3% of children with SCD at this institution experienced VTE.
- Central venous catheter (CVC) placement is a significant independent predictor of VTE in children with sickle cell disease.
Objectives:
To describe the cumulative incidence of venous thromboembolism (VTE) in children with sickle cell disease (SCD) followed at a single institution and report on the risk factors associated with VTE development.
Study Design:
Charts for all patients with SCD, aged 0-21 years, followed at Nationwide Children's Hospital over a 6-year period (January 1, 2009, to January 31, 2015) were reviewed. Data on VTE diagnosis, sex, body mass index/weight-for-length, SCD genotype, SCD clinical complications, central venous catheter (CVC) placement, and thrombophilia testing were collected.
Results:
Cumulative incidence of VTE in children with SCD followed at a single tertiary care institution was found to be 2.9% (12/414). Nine of the 12 VTE were CVC-associated. On univariate analysis, hemoglobin SS genotype (OR 10.7, 95% CI 1.4-83.5), CVC presence (OR 34.4, 95% CI 8.9-134.6), central nervous system vasculopathy (OR 19.4, 95% CI 5.6-63.4), chronic transfusion therapy (OR 30.6, 95% CI 8.9-122.2), and older age (P = .03) were associated with VTE. However, presence of CVC was the only independent risk factor identified on multivariable logistic regression analysis (OR 33.8, 95% CI 8.7-130.9).
Conclusion:
In our institution, nearly 3% of children with SCD had a history of VTE. CVC is an independent predictor of VTE in children with SCD.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis I: Introduction
EPS and iPS Cells in Disease Research
Drug Dosing: Infants and Children
Venous Thrombosis III: Interprofessional Care

